Cite
HARVARD Citation
Schmiedeberg, K. et al. (2022). Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses. Lancet. pp. e11-e13. [Online].